AYTU BIOPHARMA, INC Increase (Decrease) in Due to Related Parties
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Due to Related Parties of $0 for the 6-month period ending 2016-12-31, per its 10-Q filed 2017-02-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2017-02-09
- 2016-12-31: Increase (Decrease) in Due to Related Parties 6 month $0.00.
- 2015-12-31: Increase (Decrease) in Due to Related Parties 6 month $38.45K.
| Period end | Increase (Decrease) in Due to Related Parties 6 month |
|---|---|
| 2016-12-31 | $0.00 10-Q · filed 2017-02-09 |
| 2015-12-31 | $38.45K 10-Q · filed 2017-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |